BIOMAT Database Logo BIOMAT Database Logo

Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes. 1997

N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

A second-generation recombinant immunoblot assay (RIBA 2.0) is used in the United States to confirm infection with hepatitis C virus (HCV) in samples that are anti-HCV (enzyme immunoassay) positive. In some cases, indeterminate results of RIBA 2.0, which are defined as reactivity to a single antigen species or reactivity limited to two proteins derived from the same coding region of the HCV genome, are encountered. This study was performed to establish the significance of indeterminate RIBA 2.0 results in relation to HCV RNA detection, high positivity for the c22-3 band, and the HCV genotype as determined by direct DNA sequencing. Ninety-six samples with indeterminate RIBA 2.0 results were studied. HCV RNA was detected in 21 of 34 (62%) samples with high reactivity to c22-3 and in 8 of 62 (13%) samples with low reactivity to c22-3. The HCV genotype distribution in samples that were RIBA 2.0 indeterminate and HCV RNA positive was significantly different from that in samples of a control group with positive results for both the RIBA 2.0 and HCV PCR. These results suggest that highly positive c22-3 samples are likely to be associated with HCV viremia and that infection with less common HCV genotypes is more commonly associated with indeterminate RIBA 2.0 results.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
May 1994, Journal of clinical microbiology,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
January 1996, Journal of clinical microbiology,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
May 1995, Journal of clinical microbiology,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Hepatitis C virus infection in blood donors with indeterminate results in second-generation recombinant immunoblot assay.
June 1994, Transfusion,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples.
January 1993, Vox sanguinis,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
August 1994, The Journal of infectious diseases,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Hepatitis C virus genotypes, reactivity to recombinant immunoblot assay 2 antigens and liver disease.
July 1994, Journal of medical virology,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Serological studies and hepatitis C virus RNA in serum samples from blood donors with indeterminate results in second-generation recombinant immunoblot assay.
January 1994, Vox sanguinis,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Indeterminate second-generation hepatitis C recombinant immunoblot test: detection of hepatitis C virus infection by polymerase chain reaction.
August 1992, The Journal of infectious diseases,
N N Zein, and J J Germer, and N K Wendt, and C M Schimek, and J N Thorvilson, and P S Mitchell, and D H Persing
Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure.
July 2009, Transfusion,
Copied contents to your clipboard!